Eli Lilly stock down on Q4 guidance miss - Yahoo Finance
1 day ago · Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. Lilly revised its revenue ...
Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion …
1 day ago · Eli Lilly expects fourth-quarter 2024 revenue of approximately $13.5 billion, representing a 45% year-over-year growth compared to the consensus of $13.97 billion. ... Price Action: LLY stock is ...
Lilly provides update on 2024 revenue guidance, announces 2025 …
1 day ago · For Q4 2024, Lilly now expects worldwide revenue to be approximately $13.5 billion, representing growth of 45% compared to Q4 2023. This includes approximately $3.5 billion for Mounjaro ® and $1.9 billion for Zepbound ®. In addition to the uptake of Mounjaro and Zepbound, Lilly saw strong performance from its oncology, immunology and ...
Eli Lilly Shares Down 7.5% as Market Reacts to Slashed Q4 Forecast
1 day ago · Shares of Eli Lilly are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024.The pharmaceutical giant expects only $13.5 billion in ...
Lilly Cuts Q4 Revenue View Below Market, Lifts FY24 Outlook; …
1 day ago · The company currently plans to announce fourth-quarter results and 2025 financial guidance on February 6. In pre-market activity on the NYSE, Lilly shares were trading at $794.00, down 0.44 ...
Quarterly Results | Eli Lilly and Company
Stock Info Webcasts & Presentations. Financials. Individual Investors ... Search Lilly.com For Content... Quarterly Results Quarterly Results ... Q4 Earnings Earnings Call. Press Release 212.1 KB. Earnings Presentation 2.8 MB. Q4 2023 Financial Workbook 81.6 KB. Form 10-K.
Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5
1 day ago · Eli Lilly expects fourth-quarter 2024 revenue of approximately $13.5 billion, ... Price Action: LLY stock is down 8.03% at $775.10 at the last check on Tuesday. Read Next:
Eli Lilly issues Q4 2024 revenue guidance below consensus
1 day ago · Eli Lilly and Company (NYSE:LLY) announced on Tuesday that the pharmaceuticals company expects Q4 2024 revenue to be ~$13.5B. The consensus revenue estimate stands at $13.95B.
Lilly shares on track for worst day since 2021 after downbeat …
1 day ago · Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street estimates, marking the second time sales have disappointed since the ...
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip
22 hours ago · Eli Lilly and Company (LLY Quick Quote LLY - Free Report) dropped 6.6% in the Jan. 14 trading session after slashing its revenue guidance for the fourth quarter and fiscal 2024, citing lower-than ...
- Some results have been removed